Regulation - Reproductive, Novartis

Filter

Current filters:

ReproductiveNovartis

Popular Filters

Mylan settles with Novartis over Vivelle-Dot; Impax files for generic Fentora

21-11-2011

US generics drugmaker Mylan (Nasdaq: MYL) says it has settled a patent litigation law suit with the US…

CephalonCIMA LabsFentoraGenericsImpax LaboratoriesMylan LaboratoriesNeurologicalNorth AmericaNovartisPatentsRegulationReproductiveVivelle-Dot

Company Spotlight

ImmunoGen

ImmunoGen

Back to top